The Voice: Top Eight Contestants Revealed















11/20/2012 at 10:05 PM EST







From left: Adam Levine, Cee Lo Green, Christina Aguilera, Blake Shelton and host Carson Daly


Mark Seliger/NBC


Following what Blake Shelton called the "best episode of The Voice we've ever had", spirited group performances on Tuesday night's show kept the energy up and distracted viewers just long enough from the business at hand – impending eliminations.

Christina Aguilera brought the heat with her song "Let There Be Love." Rascal Flatts shared their hit "Changed." Later, Adam Levine performed a rendition of Queen's "Crazy Little Thing Called Love," followed by the contestants taking on Pat Benatar's "Hit Me with Your Best Shot."

But once again, the decisions about who would stay and who would go were completely up to the viewers. No input from the coaches could save contestants this time. Keep reading to find out which contestants will sing again next week ...

The first round of results turned out to be good news for Nicholas David and Cassadee, later joined by Dez Duron and Cody Belew in the top eight.

America also gave Terry McDermott, Melanie Martinez, Trevin Hunte and Amanda Brown another shot at superstardom.

That means Bryan Keith and Sylvia Yacoub won't be singing again on Monday night's episode.

Read More..

OB/GYNs back over-the-counter birth control pills

WASHINGTON (AP) — No prescription or doctor's exam needed: The nation's largest group of obstetricians and gynecologists says birth control pills should be sold over the counter, like condoms.

Tuesday's surprise opinion from these gatekeepers of contraception could boost longtime efforts by women's advocates to make the pill more accessible.

But no one expects the pill to be sold without a prescription any time soon: A company would have to seek government permission first, and it's not clear if any are considering it. Plus there are big questions about what such a move would mean for many women's wallets if it were no longer covered by insurance.

Still, momentum may be building.

Already, anyone 17 or older doesn't need to see a doctor before buying the morning-after pill — a higher-dose version of regular birth control that can prevent pregnancy if taken shortly after unprotected sex. Earlier this year, the Food and Drug Administration held a meeting to gather ideas about how to sell regular oral contraceptives without a prescription, too.

Now the influential American College of Obstetricians and Gynecologists is declaring it's safe to sell the pill that way.

Wait, why would doctors who make money from women's yearly visits for a birth-control prescription advocate giving that up?

Half of the nation's pregnancies every year are unintended, a rate that hasn't changed in 20 years — and easier access to birth control pills could help, said Dr. Kavita Nanda, an OB/GYN who co-authored the opinion for the doctors group.

"It's unfortunate that in this country where we have all these contraceptive methods available, unintended pregnancy is still a major public health problem," said Nanda, a scientist with the North Carolina nonprofit FHI 360, formerly known as Family Health International.

Many women have trouble affording a doctor's visit, or getting an appointment in time when their pills are running low — which can lead to skipped doses, Nanda added.

If the pill didn't require a prescription, women could "pick it up in the middle of the night if they run out," she said. "It removes those types of barriers."

Tuesday, the FDA said it was willing to meet with any company interested in making the pill nonprescription, to discuss what if any studies would be needed.

Then there's the price question. The Obama administration's new health care law requires FDA-approved contraceptives to be available without copays for women enrolled in most workplace health plans.

If the pill were sold without a prescription, it wouldn't be covered under that provision, just as condoms aren't, said Health and Human Services spokesman Tait Sye.

ACOG's opinion, published in the journal Obstetrics & Gynecology, says any move toward making the pill nonprescription should address that cost issue. Not all women are eligible for the free birth control provision, it noted, citing a recent survey that found young women and the uninsured pay an average of $16 per month's supply.

The doctors group made clear that:

—Birth control pills are very safe. Blood clots, the main serious side effect, happen very rarely, and are a bigger threat during pregnancy and right after giving birth.

—Women can easily tell if they have risk factors, such as smoking or having a previous clot, and should avoid the pill.

—Other over-the-counter drugs are sold despite rare but serious side effects, such as stomach bleeding from aspirin and liver damage from acetaminophen.

—And there's no need for a Pap smear or pelvic exam before using birth control pills. But women should be told to continue getting check-ups as needed, or if they'd like to discuss other forms of birth control such as implantable contraceptives that do require a physician's involvement.

The group didn't address teen use of contraception. Despite protests from reproductive health specialists, current U.S. policy requires girls younger than 17 to produce a prescription for the morning-after pill, meaning pharmacists must check customers' ages. Presumably regular birth control pills would be treated the same way.

Prescription-only oral contraceptives have long been the rule in the U.S., Canada, Western Europe, Australia and a few other places, but many countries don't require a prescription.

Switching isn't a new idea. In Washington state a few years ago, a pilot project concluded that pharmacists successfully supplied women with a variety of hormonal contraceptives, including birth control pills, without a doctor's involvement. The question was how to pay for it.

Some pharmacies in parts of London have a similar project under way, and a recent report from that country's health officials concluded the program is working well enough that it should be expanded.

And in El Paso, Texas, researchers studied 500 women who regularly crossed the border into Mexico to buy birth control pills, where some U.S. brands sell over the counter for a few dollars a pack. Over nine months, the women who bought in Mexico stuck with their contraception better than another 500 women who received the pill from public clinics in El Paso, possibly because the clinic users had to wait for appointments, said Dr. Dan Grossman of the University of California, San Francisco, and the nonprofit research group Ibis Reproductive Health.

"Being able to easily get the pill when you need it makes a difference," he said.

___

Online:

OB/GYN group: http://www.acog.org

Read More..

Asian shares steady, refocusing on U.S. fiscal cliff

TOKYO (Reuters) - Asian shares steadied on Wednesday, after a two days of gains, as investors refocused on the risk of a U.S. fiscal crisis following Federal Reserve Chairman Ben Bernanke's remarks that the budget impasse was already damaging growth.


U.S. stocks halted a two-day rally on Tuesday, while European shares edged higher on expectations euro zone finance ministers will approve the next tranche of bailout cash for Greece.


MSCI's broadest index of Asia-Pacific shares outside Japan <.miapj0000pus> was little changed, with Australian shares <.axjo> easing 0.1 percent and South Korean shares <.ks11> opening up 0.3 percent.


Japan's Nikkei average <.n225> opened up 0.8 percent to a fresh two-month high, buoyed by a weaker yen. <.t/>


Bernanke on Tuesday repeated a warning that failing to halt the $600 billion "fiscal cliff" in expiring tax cuts and government spending reductions could lead to recession, and said worries over how budget negotiations will be resolved were already damaging growth.


He also reiterated the Fed's guidance for keeping interest rates new zero until at least mid-2015, but offered few clues as to how the central bank might tweak its bond-purchase program at the start of next year.


"We remain wary of the fiscal cliff," Barclays Capital said in a research note. "We think the uncertainty associated with the current range of fiscal outcomes during the tax cliff negotiations and beyond is under appreciated by investors."


As activity was slowing ahead of the U.S. Thanksgiving long weekend, traders were eyeing the outcome of the European meeting which was still underway in early Asia on Wednesday.


Euro zone finance ministers are considering allowing Athens to buy back up to 40 billion euros of its own bonds at a discount as one of a number of measures to cut Greek debt to 120 percent of GDP within the next eight years.


"Virtually everyone is expecting the Eurogroup to deliver, so the risk of them disappointing could be relatively high. Therefore, a two pronged approach may be prudent to prepare for both sides of the ledger," Neal Gilbert, currency strategist at GFT, said in a note.


The euro was steady around $1.2815, after rising to a two-week high of $1.28295 on Tuesday.


The dollar has been underpinned broadly by data indicating a moderate U.S. recovery taking root, while the yen has been undermined by expectations that Japan's elections on December 16 will see a new government that could push for more aggressive monetary and fiscal stimulus to bolster the sagging economy.


Data on Wednesday showed Japanese exports fell 6.5 percent in October from a year ago, the fifth month in a row of drops, weighed down by weakening global demand and a territorial row with China, its top export destination.


In the U.S. on Tuesday, a report showed U.S. housing starts rose to the highest rate in more than four years in October.


The dollar rose to a seven-month high against the yen of 81.80 yen in early Asia on Wednesday. The euro was at 104.64 yen after hitting a peak of 104.77, its highest point since May 4, on Tuesday.


Oil prices fell on Tuesday amid signs of a ceasefire between Palestinians and Israelis. U.S. Secretary of State Hillary Clinton met Israeli Prime Minister Benjamin Netanyahu on Tuesday and pledged to work for a truce in the Gaza Strip "in the days ahead".


But U.S. crude futures were up 0.6 percent to $87.30 a barrel, as Palestinian rocket fire and Israeli air strikes continued.


(Editing by Michael Perry)


Read More..

Intel CEO Paul Otellini to retire in surprise move
















SAN FRANCISCO (AP) — Intel CEO Paul Otellini dropped a bombshell on the company’s board of directors last week, telling them in private that he plans to retire from the world’s largest maker of microprocessors in May. Otellini‘s move comes at a time when Intel faces a shaky economy and a mobile gadget craze that is eating away at demand for its PC chips —and it gives the company just six months to find a new leader.


Intel‘s board expected the 62-year-old Otellini to remain chief executive until the company’s customary retirement age of 65. The company announced his impending departure on Monday.













“The decision was entirely Paul’s,” said Intel spokesman Paul Bergevin. “The board accepted his decision with regret.”


Otellini will be ending a nearly 40-year career with Intel, including an eight-year stint as CEO by the time he leaves. He joined the Santa Clara, Calif. company after graduating from the nearby University of California at Berkeley and worked his way up the ranks before succeeding Craig Barrett as CEO in May 2005.


“It’s time to move on and transfer Intel‘s helm to a new generation of leadership,” Otellini said in a statement.


In another statement, Intel Chairman Andy Bryant praised Otellini for leading the company through “challenging times and market transitions.”


Intel‘s board plans to consider candidates inside and outside the company as it searches for Otellini’s successor. Otellini will be involved in the search.


Otellini and the four other men who have been Intel‘s CEO during the company’s 45-year history have all been promoted from within. The company’s board is believed to be leaning in that direction again.


Intel identified the leading internal candidates Monday by anointing three of Otellini’s current lieutenants as executive vice presidents. They are: Renee James, head of Intel‘s software business; Brian Krzanich, chief operating officer and head of worldwide manufacturing; and Stacy Smith, chief financial officer and director of corporate strategy.


If recent history is any indication, Krzanich has the inside track to become Intel‘s CEO. Both Barrett and Otellini served as chief operating officer before becoming CEO.


Although Otellini is generally well regarded, he has faced criticism for initially underestimating the impact that smartphones and tablet computers would have on the personal computer market. It was a pivotal change that also confounded Microsoft Corp. CEO Steve Ballmer, whose software company makes the Windows operating system that runs most of the PCs relying on Intel‘s chips.


“The shift came more quickly than they expected, and when they did finally see what was happening, they were a little late to react,” said technology analyst Patrick Moorhead of Moor Insights & Strategy.


Indeed, in 2008, nearly 300 million PCs were sold and most of them were powered by Microsoft‘s Windows and Intel‘s microchips, according to Forrester Research. Some 142 million smartphones sold that year, at a time when the tablet market hadn’t really taken off. That wouldn’t happen until Apple‘s 2010 release of the iPad.


By contrast, this year, Forrester estimates 330 million PCs will be sold worldwide compared with 665 million smartphones and just over 100 million tablets. By 2016, Forrester predicts annual sales of PCs will rise only slightly to 370 million machines while more than 1.6 billion smartphones and tablets will be purchased.


The fates of Intel and Microsoft have been so tightly wound for the past 30 years that computers using a combination of their chips and software are famously known as “Wintel” machines.


Now, much of the technology industry is questioning whether Intel and Microsoft can catch up in the mobile market to ensure their products remain as essential — and profitable — in the future as they have been in the past three decades.


It’s a challenge that Ballmer, 56, is confident he can tackle. He signaled his intent to remain Microsoft‘s CEO earlier this month when he ushered out the head of the company’s Windows division because of philosophical differences over the company’s future direction. For whatever reasons, Otellini concluded it was time for new leadership at Intel — an opinion that many investors share, according to RBC Capital Markets analyst Doug Freedman.


“A shift in leadership could be welcome news to investors as Intel could be in greater position to broaden its portfolio into higher growth markets,” Freedman wrote in a Monday research note.


Intel‘s stock was unchanged at $ 20.19 shortly before the market closed Monday. The stock has fallen more than 20 percent during Otellini’s reign. Most of the decline occurred this year amid concerns about the company’s ability to adjust to mobile computing and weakening demand for its core products in countries with troubled economies, particularly in Europe and China. The company blamed the poor economy for a 14 percent drop in its earnings during its most recent quarter.


Intel‘s chips have become even more dominant in the PC computer market during Otellini’s tenure, helping to boost the company’s annual revenue from $ 39 billion in 2005 to $ 54 billion last year. Besides supplying Windows-powered PCs, Otellini also scored a coup in 2006 when he convinced Apple to start using Intel chips in Mac computers instead of IBM Corp.’s microprocessors.


But Apple‘s pioneering work in smartphones and tablet computers also muddled Intel‘s future. Both the iPhone and iPad inspired a wave of sophisticated handheld devices that are undercutting demand for desktop and laptop machines that house Intel processors.


Most tablets rely on a technology licensed from British chip designer ARM Holdings Plc. Even Microsoft has tweaked the latest version of the Windows operating system so it works on ARM chips.


Other chip makers such as Qualcomm Inc. have developed less expensive microprocessors that have eclipsed Intel in the smartphone market. Qualcomm‘s inroads in the mobile market are a key reason why its stock has soared by more than 70 percent while Otellini was running Intel.


The contrasting performances of the two companies’ stocks enabled Qualcomm to surpass Intel as the world’s most valuable chip maker. Qualcomm‘s market value now stands at about $ 106 billion versus $ 100 billion for Intel.


Even though its stock under Otellini has lagged the rest of the market, Intel‘s ongoing prosperity has enabled the company to reward shareholders in other ways. Intel has paid stock dividends totaling $ 23.5 billion under Otellini as its quarterly payments rose 8 cents per share in 2005 to 22.5 cents per share currently.


Gadgets News Headlines – Yahoo! News



Read More..

Miley Cyrus Celebrates in New York - with Her Entire Family!















11/19/2012 at 07:05 PM EST







From left: Noah, Bill Ray, Tish, Miley, Brandi and Braison Cyrus


Bruce Glikas/Filmmagic


The Cyrus family has a lot to be thankful for this year.

Miley Cyrus is celebrating her 20th birthday on Friday. Her dad, Billy Ray Cyrus, is starring as slick lawyer Billy Flynn in the Broadway hit musical Chicago. And it looks like (practically) the whole family is together for the occasions.

Photos show Billy Ray – dressed in a tuxedo – his wife Tish and their kids, Miley, 19, Noah, 12, Brandi, 25, and Braison, 18, all posing together backstage at the Ambassador Theater in New York City on Sunday. (Brother Trace is the only one absent.)

"The whole family had a great time," an observer tells PEOPLE.

They came backstage at intermission to spend time with Billy Ray in his dressing room, and again after the show to meet some of his fellow cast members.

Billy Ray, who began his Broadway run recently, told PEOPLE that his family hadn't come to see him yet partly because he wanted to get comfortable in the role. "I gotta get my legs up [before they see it]," he said. "I think everybody's coming in for Thanksgiving. So we'll see what happens."

Now that they've seen it, it seems his family is giving his performance a thumbs-up. "So glad to be back with my daddy (@billyraycyrus) for the first time in 3 MONTHS!! He was so great on broadway," Noah Tweeted on Monday.

Miley, too, is having a blast in the Big Apple. "What a dope morning. So many fans outside my hotel this a.m. in NYC. If there's this much chaos NOW imagine when I drop this record! #ohsnap," she Tweeted.

As for Billy Ray, whose Chicago run ends Dec. 23, he says taking the part on Broadway has been great fun – and a great challenge.

"I couldn't come up here and do something predictable," he says of the role. "I was offered Rock of Ages, and my instincts said, 'That's a bit predictable for me.' "

But when the role of Billy Flynn came up, Ray explained, "He's the total opposite of me" – and that was just what he wanted.

For more on Billy Ray Cyrus – including what he does (and doesn't) know about Miley's wedding plans – pick up PEOPLE, on newsstands Friday

Read More..

New push for most in US to get at least 1 HIV test

WASHINGTON (AP) — There's a new push to make testing for the AIDS virus as common as cholesterol checks.

Americans ages 15 to 64 should get an HIV test at least once — not just people considered at high risk for the virus, an independent panel that sets screening guidelines proposed Monday.

The draft guidelines from the U.S. Preventive Services Task Force are the latest recommendations that aim to make HIV screening simply a routine part of a check-up, something a doctor can order with as little fuss as a cholesterol test or a mammogram. Since 2006, the Centers for Disease Control and Prevention also has pushed for widespread, routine HIV screening.

Yet not nearly enough people have heeded that call: Of the more than 1.1 million Americans living with HIV, nearly 1 in 5 — almost 240,000 people — don't know it. Not only is their own health at risk without treatment, they could unwittingly be spreading the virus to others.

The updated guidelines will bring this long-simmering issue before doctors and their patients again — emphasizing that public health experts agree on how important it is to test even people who don't think they're at risk, because they could be.

"It allows you to say, 'This is a recommended test that we believe everybody should have. We're not singling you out in any way,'" said task force member Dr. Douglas Owens, of Stanford University and the Veterans Affairs Palo Alto Health Care System.

And if finalized, the task force guidelines could extend the number of people eligible for an HIV screening without a copay in their doctor's office, as part of free preventive care under the Obama administration's health care law. Under the task force's previous guidelines, only people at increased risk for HIV — which includes gay and bisexual men and injecting drug users — were eligible for that no-copay screening.

There are a number of ways to get tested. If you're having blood drawn for other exams, the doctor can merely add HIV to the list, no extra pokes or swabs needed. Today's rapid tests can cost less than $20 and require just rubbing a swab over the gums, with results ready in as little as 20 minutes. Last summer, the government approved a do-it-yourself at-home version that's selling for about $40.

Free testing is available through various community programs around the country, including a CDC pilot program in drugstores in 24 cities and rural sites.

Monday's proposal also recommends:

—Testing people older and younger than 15-64 if they are at increased risk of HIV infection,

—People at very high risk for HIV infection should be tested at least annually.

—It's not clear how often to retest people at somewhat increased risk, but perhaps every three to five years.

—Women should be tested during each pregnancy, something the task force has long recommended.

The draft guidelines are open for public comment through Dec. 17.

Most of the 50,000 new HIV infections in the U.S. every year are among gay and bisexual men, followed by heterosexual black women.

"We are not doing as well in America with HIV testing as we would like," Dr. Jonathan Mermin, CDC's HIV prevention chief, said Monday.

The CDC recommends at least one routine test for everyone ages 13 to 64, starting two years younger than the task force recommended. That small difference aside, CDC data suggests fewer than half of adults under 65 have been tested.

"It can sometimes be awkward to ask your doctor for an HIV test," Mermin said — the reason making it routine during any health care encounter could help.

But even though nearly three-fourths of gay and bisexual men with undiagnosed HIV had visited some sort of health provider in the previous year, 48 percent weren't tested for HIV, a recent CDC survey found. Emergency rooms are considered a good spot to catch the undiagnosed, after their illnesses and injuries have been treated, but Mermin said only about 2 percent of ER patients known to be at increased risk were tested while there.

Mermin calls that "a tragedy. It's a missed opportunity."

___

Online:

Task force recommendation: http://www.uspreventiveservicestaskforce.org

Read More..

Budget talk optimism spurs Wall Street rally

NEW YORK (Reuters) - Stocks bounced higher for a second consecutive session on Monday as investors were encouraged by the early atmosphere surrounding talks to tackle the nation's fiscal crunch.


Stronger-than-expected earnings from Lowe's and Tyson Foods, as well as encouraging housing data, also contributed to the market's advance. Tyson and Lowe's were the top two percentage gainers on the S&P 500.


The S&P 500 is up more than 2 percent in the last two sessions as rhetoric from legislators over the weekend suggests a deal could be reached to stave off the looming "fiscal cliff," a series of tax and spending changes that will begin to take effect in the new year. The two sides are still far apart in negotiations, however.


The benchmark S&P index had fallen 5.3 percent between Election Day and Friday's rebound, as investors took the opportunity to sell stocks - including some of the year's best performers - just in case Washington cannot come to an agreement and taxes on dividends and capital gains rise in 2013.


"Everyone is quietly breathing a sigh of relief, because frankly, we are no longer looking over the edge of a cliff, we are looking at an opportunity to step back and recalibrate," said Peter Kenny, managing director at Knight Capital in Jersey City, New Jersey.


However, the rebound could be a short-lived reprieve from the sharp declines and market volatility could still rise, depending on progress in negotiations. A number of sectors were considered oversold on a technical basis - suggesting a buying opportunity.


"There is no question, what lit the fuse was constructive conversation, constructive talking points out of Washington that has done far more to help the market than anything else - the backdrop is the oversold" market, Kenny said.


Monday's advance marked the biggest percentage gain for the S&P 500 since November 6, when the European Central Bank announced a new bond-buying program aimed at containing the region's debt crisis.


Shares of Lowe's Cos Inc , the world's No. 2 home improvement chain, jumped 6.2 percent to $33.96 to hit a 52-week high after the company reported higher-than-expected quarterly profit and raised its full-year sales forecast.


Home improvement chains tend to benefit as housing strengthens. U.S. home resales unexpectedly increased in October, while separate data showed homebuilder sentiment rose to its highest level in over six years in November.


The PHLX Housing Index <.hgx> rose 1.8 percent.


The Dow Jones industrial average <.dji> gained 207.65 points, or 1.65 percent, at 12,795.96. The Standard & Poor's 500 Index <.spx> was up 27.01 points, or 1.99 percent, at 1,386.89. The Nasdaq Composite Index <.ixic> was up 62.94 points, or 2.21 percent, at 2,916.07.


The S&P edged above its 200-day moving average at around 1,382, which has acted as a resistance level since a drop below the technically significant mark on November 8.


Tyson Foods Inc beat expectations and gave an upbeat forecast, sending its stock up 10.9 percent to $18.72.


Intel shares edged higher, up 0.3 percent to $20.25 after the company said its chief executive will retire in May.


Commodities prices surged, boosting shares of resource companies. Freeport-McMoRan rose 4.1 percent to $38.28, while U.S. Steel rose 5.3 percent to $21.15. The S&P materials sector <.gspm> advanced 2.9 percent as the best performing of the 10 major S&P sectors.


Volume was light and is expected to remain so throughout the Thanksgiving Day holiday-shortened trading week, with about 6.14 billion shares traded on the New York Stock Exchange, NYSE MKT and Nasdaq, below the daily average of 6.49 billion.


Advancing stocks outnumbered declines on the NYSE by 2,678 to 350, while on the Nasdaq, advancers beat decliners 1,949 to 521.


(Reporting by Chuck Mikolajczak; Editing by Dan Grebler)


Read More..

More diplomacy to try to halt Israel-Gaza fighting

GAZA/JERUSALEM (Reuters) - Hostilities between Islamist militants and Israel entered a sixth day on Monday as diplomatic efforts were set to intensify to try to stop rocket fire from the Gaza Strip and Israeli air strikes on Gaza.


International pressure for a ceasefire seemed certain to mount after the deadliest single incident in the flare-up on Sunday claimed the lives of at least 11 Palestinian civilians, including four children.


Three people, including two children, were killed and 30 others were injured in the latest air strike before dawn on Monday on a family home in the Zeitoun neighborhood in Gaza City, medical officials said. The Israeli military had no immediate comment and was checking.


United Nations Secretary General Ban Ki-moon was due to arrive in Cairo to add his weight to the truce efforts. Egypt has taken the lead in trying to broker a ceasefire and its officials met the parties on Sunday.


Israeli media said a delegation from Israel had been to Cairo for talks on ending the fighting, although a government spokesman declined to comment on the matter.


Egyptian President Mohamed Mursi met Khaled Meshaal, the political leader of Hamas, which runs the Gaza Strip, and Ramadan Shallah of Islamic Jihad as part of the mediation efforts, but a statement did not say if talks were conclusive.


Izzat Risheq, a close aide to Meshaal, wrote in a Facebook message that Hamas would agree to a ceasefire only after Israel "stops its aggression, ends its policy of targeted assassinations and lifts the blockade of Gaza".


Listing Israel's terms, Vice Prime Minister Moshe Yaalon wrote on Twitter: "If there is quiet in the south and no rockets and missiles are fired at Israel's citizens, nor terrorist attacks engineered from the Gaza Strip, we will not attack."


Israel withdrew settlers from Gaza in 2005 and two years later Hamas took control of the impoverished enclave, which the Israelis have kept under blockade.


The 11 Palestinian civilians were apparently killed during an Israeli attack on a militant, which brought a three-storey house crashing down on them.


Gaza health officials have said 78 Palestinians, 23 of them children and several women, have been killed in Gaza since Israel's offensive began. Hundreds have been wounded.


GRAVE CONCERN


Ban expressed grave concern in a statement before setting off for the region. He will visit Israel on Tuesday.


"I am deeply saddened by the reported deaths of more than ten members of the Dalu family... (and) by the continuing firing of rockets against Israeli towns, which have killed several Israeli civilians. I strongly urge the parties to cooperate with all efforts led by Egypt to reach an immediate ceasefire," he said.


Israeli Prime Minister Benjamin Netanyahu said he had assured world leaders that Israel was doing its utmost to avoid causing civilian casualties in the military showdown with Hamas.


Gaza militants launched dozens of rockets into Israel and targeted its commercial capital, Tel Aviv, for a fourth day on Sunday. Israel's "Iron Dome" missile shield shot down all three rockets.


In scenes recalling Israel's 2008-2009 winter invasion of Gaza, tanks, artillery and infantry have massed in field encampments along the sandy, fenced-off border with Gaza and military convoys moved on roads in the area.


Israel has authorized the call-up of 75,000 reservists, although there was no immediate sign when or whether they might be needed in a ground invasion.


Israel's operation has so far drawn Western support for what U.S. and European leaders have called its right to self-defense, but there have also been a growing number of appeals to seek an end to the hostilities.


Netanyahu said Israel was ready to widen its offensive.


"We are exacting a heavy price from Hamas and the terrorist organizations and the Israel Defence Forces are prepared for a significant expansion of the operation," he said at a cabinet meeting on Sunday, but gave no further details.


The Israeli military said 544 rockets fired from Gaza have hit Israel since Wednesday, killing three civilians and wounding dozens. Some 302 rockets were intercepted by Iron Dome and 99 failed to reach Israel and landed inside the Gaza Strip.


Israel's declared goal is to deplete Gaza arsenals and force Hamas to stop rocket fire that has bedeviled Israeli border towns for years. The rockets now have greater range, putting Tel Aviv and Jerusalem within their reach.


The southern resort city of Eilat was apparently added to the list of targets when residents said they heard an explosion thought to be a rocket, but it caused no damage or casualties, police said.


Eilat is thought to be well out of the range of any rocket in possession of Hamas or any other Gaza group. But Palestinian militants have in the recent past fired rockets at Eilat and its surroundings, using Egypt's Sinai desert as a launch site.


SWORN ENEMIES


Hamas and other groups in Gaza are sworn enemies of the Jewish state which they refuse to recognize and seek to eradicate, claiming all Israeli territory as rightfully theirs.


Hamas won legislative elections in the Palestinian Territories in 2006 but a year later, after the collapse of a unity government under President Mahmoud Abbas the Islamist group seized control of Gaza in a brief and bloody civil war with forces loyal to Abbas.


Abbas then dismissed the Hamas government led by the group's leader Ismail Haniyeh but he refuses to recognize Abbas' authority and runs Gazan affairs.


While it is denounced as a terrorist organization in the West, Hamas enjoys widespread support in the Arab world, where Islamist parties are on the rise.


Western-backed Abbas and Fatah hold sway in the Israeli-occupied West Bank from their seat of government in the town of Ramallah. The Palestinians seek to establish an independent state in the West Bank and the Gaza Strip with East Jerusalem as its capital.


(Writing by Ori Lewis; editing by Christopher Wilson)


Read More..

EU drug regulator OKs Novartis' meningitis B shot

LONDON (AP) — Europe's top drug regulator has recommended approval for the first vaccine against meningitis B, made by Novartis AG.

There are five types of bacterial meningitis. While vaccines exist to protect against the other four, none has previously been licensed for type B meningitis. In Europe, type B is the most common, causing 3,000 to 5,000 cases every year.

Meningitis mainly affects infants and children. It kills about 8 percent of patients and leaves others with lifelong consequences such as brain damage.

In a statement on Friday, Andrin Oswald of Novartis said he is "proud of the major advance" the company has made in developing its vaccine Bexsero. It is aimed at children over two months of age, and Novartis is hoping countries will include the shot among the routine ones for childhood diseases such as measles.

Novartis said the immunization has had side effects such as fever and redness at the injection site.

Recommendations from the European Medicines Agency are usually adopted by the European Commission. Novartis also is seeking to test the vaccine in the U.S.

Read More..

Asian shares rise on positive U.S. tone, yen slips

TOKYO (Reuters) - Asian shares rose on Monday, boosted by a positive tone in U.S. equities last week, while the yen fell to a near seven-month low against the dollar on expectations a new government after next month's election in Japan may deliver more stimulus.


MSCI's broadest index of Asia-Pacific shares outside Japan <.miapj0000pus> rose 0.6 percent, recovering from Friday's nine-week low.


Its energy sector <.miapjen00pus> outperformed as mounting supply concerns on escalating tension from Israeli air strikes on the Gaza Strip and Hamas rocket attacks on Israel underpinned oil prices.


The material sector <.miapjmt00pus> also were among top gainers as London copper rallied 1 percent to $7.684 a tonne on expectations for economic measures in China and hopes for a solution to the U.S. fiscal crisis.


Australian shares <.axjo> inched up 0.2 percent but Shanghai shares <.ssec> underperformed with a 0.3 percent drop, hovering near the seven-week low touched on Friday.


"We had some positive leads from the U.S. on Friday. Our market had been underperforming last week," Peter Esho, chief market analyst at City Index, said of Australian equities. "There's some hope that the negotiations in the U.S. around the fiscal situation may somewhat improve -- the prospects around that may improve this week."


Japan's Nikkei average <.n225>, which bucked the broad Asian downtrend on Friday and surged 2.2 percent, extended gains with a 1.3 percent climb to a two-month high. <.t/>


Speculation that the leader of the opposition Liberal Democratic Party, which is expected to win the December 16 elections, will call for more stimulus including further aggressive easing by the Bank of Japan also undermined the yen.


The BOJ begins a two-day policy meeting on Monday, and is expected to refrain from taking fresh policy steps.


The dollar hit a near seven-month high against the yen at 81.59 yen on Monday. A weaker yen helps support the economy and boosts sentiment for Japanese equities investors.


A senior trader at a foreign bank said investors had been underweight Japanese equities and the rally could have further to go as they start to put their money into Japan, advising investors to cover their positions in very heavily short-sold sectors such as electronics.


FISCAL CLIFF, GREECE EYED


Aside from Japanese politics, market players closely watched negotiations among U.S. Congressional leaders to avoid a budget crisis, and prepared for European officials' meeting on Tuesday to discuss aid for debt-stricken Greece.


Hope that U.S. politicians would find common ground to steer clear of the "fiscal cliff" boosted U.S. stocks on Friday. European shares sank to a 3-1/2-month closing low, for their worst week since the end of May, on persistent concerns over U.S. fiscal policy and the euro zone debt crisis.


U.S. Treasury yields fell to their lowest levels in over two months on Friday as skepticism over the U.S. budget talks drew safe-haven bids.


Top lawmakers from both major U.S. political parties on Friday hinted at the possibility of a budget compromise that involves spending cuts and additional revenue, although they were short on details.


"The good news is the tone of Friday's White House meeting but the prospect of no agreement until at least mid-December fits our view that the two sides are starting negotiations from rather distant points," Sean Callow, senior currency strategist at Westpac bank in Sydney, said in a note.


"As such, there will be plenty of negative headlines in coming weeks that weigh on Treasury yields and boost USD, which is yet again trading like a safe haven even when the bad news is generated by the US."


The dollar fell 0.3 percent, retreating from a two-month high of 81.455 hit on Friday against a basket of key currencies <.dxy>. The drop in the dollar supported gold, which added 0.5 percent to $1,722.39 an ounce.


The euro rose 0.3 percent to $1.2772, with traders waiting to know whether euro zone finance ministers and International Monetary Fund's Managing Director Christine Lagarde would agree on how to make Greece's debt manageable.


"As the EU prepares a bundled aid package to avert a Greek default, headlines coming out of the meeting may fuel a relief rally in the euro, but we will maintain our bearish forecast for the single currency as the region faces a deepening recession," said David Song, currency analyst at DailyFX.


U.S. crude futures rose 0.8 percent to 87.57 a barrel and Brent rose 0.6 percent to $109.59.


Asian credit market spreads on the iTraxx Asia ex-Japan investment-grade index were little changed.


(Additional reporting by Thuy Ong and; Ian Chua in Sydney, Dominic Lau in Tokyo; Editing by Eric Meijer)


Read More..